SELP and neuroblastoma: Thus, our studies not only underscore the relevance of therapeutic targeting of neuroblastoma surface glycoproteins, but also highlight the substantial heterogeneity in molecular signaling response in tumor cells following binding of glycoproteins such as P-selectin.